> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss Geron Imetelstat NDA
- URL: https://www.fdaweb.com/panel-to-discuss-geron-imetelstat-nda/
- Published: 2024-01-30T12:00:00.000Z
- Updated: 2026-09-14T14:21:37.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5156246

*Federal Register* notice: FDA is announcing a 3/14 Oncologic Drugs Advisory Committee meeting. Panel members are scheduled to discuss a Geron NDA for imetelstat for injection, indicated for treating transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes who have failed to respond or have lost response to or are ineligible for erythropoiesis-stimulating agents. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-01-30/pdf/2024-01797.pdf?ref=fdaweb.com).